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Abstract.  The neural cell adhesion molecule 
(N-CAM) of rodents comprises three distinct proteins 
of Mr 180,000, 140,000, and  120,000 (designated 
N-CAM-180, -140, and -120).  They are expressed in 
different proportions by different tissues and cell types, 
but the individual contribution of each form to cell 
adhesion is presently unknown.  Previous studies have 
shown that the two N-CAM species of higher relative 
molecular mass span the membrane whereas N-CAM- 
120 lacks a transmembrane domain and can be 
released from the cell surface by phosphatidylinositol- 
specific phospholipase C. In this report,  we provided 
evidence that N-CAM-120 contained covalently bound 
phosphatidylinositol and studied N-CAM-120 from its 
biosynthesis to its membrane insertion and finally to 
its release from the cell surface. Evidence was 
presented showing that the lipid tail of N-CAM-120 
contained ethanolamine as is the case for other lipid- 
linked molecules.  The phospholipid anchor was at- 
tached to the protein during the first minutes after 
completion of the polypeptide chain.  This process 
took place in the endoplasmic reticulum as judged 
from endoglycosidase H digestion experiments.  Im- 
mediately after a 2-min pulse with [35S]methionine,  we 
detected also a  short-lived precursor that had not yet 
acquired the lipid tail.  Pulse-chase studies established 
that N-CAM-120 was transported to the cell surface 
from which it was slowly released into the extracellu- 
lar milieu.  The molecules recovered in the incubation 
medium appeared to have lost all of their bound fatty 
acid but only around half of the ethanolamine.  Upon 
fractionation of brain tissue,  "075  % of N-CAM-120 
was recovered with a membrane fraction and '0,025  % in 
a  membrane-free supernatant.  A  small proportion 
(,06%) was found to be resistant to extraction by non- 
ionic detergent.  A major posttranslational  modification 
of N-CAM is polysialylation. Our results showed that 
also N-CAM-120 was polysialylated in the young post- 
natal brain and released in this form from cultured 
cerebellar cells. The presence of N-CAM in a form 
that can be released from the cell surface and accumu- 
lates in the extracellular fluid suggests a novel mecha- 
nism by which N-CAM-mediated adhesion may be 
modulated. 
T 
H~ neural cell adhesion molecule (N-CAM)  ~  is a cell 
surface glycoprotein that serves as a ligand in the for- 
marion of cell-cell bonds (see 12, 16, 44 for reviews) 
and may also be involved in cell-substrate  interactions  (8). 
N-CAM is expressed in a variety of structures during  em- 
bryonic development  but it is largely restricted to neurones 
and glial cells in the normal adult animal (see reference 44). 
N-CAM-mediated adhesion appears to play a central  role 
in various developmental  events including  the orderly out- 
growth of axons (21, 48, 50), cell pattern  formation  (6), and 
nerve-muscle  interactions  (46).  N-CAM exists  in  several 
1. Abbreviations used in this paper: endo H, endoglycosidase  H; N-CAM, 
neural cell adhesion molecule; P, postnatal day; PI, phosphatidylinositol; 
PI-PLC, phosphatidylinositol-specific phospholipase C; RIPA buffer, 50 mM 
Tris HC1, pH 8.0, 150 mM NaCI,  1% NP-40,  1% deoxycholate, 0.1% SDS; 
VSG, variant surface glycoprotein  of Trypanosoma brucei. 
molecular forms that differ at the carbohydrate  and protein 
level. They are selectively expressed by different cell types 
and during different stages of development (reviewed in ref- 
erence 45). The most striking variations in N-CAM glycosy- 
lation involve differences in the polymer length of polysialo- 
syl residues.  More highly  sialylated  forms are prevalent  in 
immature tissues and are gradually  replaced by less sialy- 
lated forms as development proceeds (19, 26). Three protein 
isoforms of N-CAM have been isolated from rodent tissues. 
In the mouse, their desialo-forms migrate in SDS-polyacryl- 
amide gels with apparent Mrs of 180,000, 140,000 and 120,000 
(25,  26,  31). The corresponding rat proteins migrate  with 
slightly higher relative molecular masses (35). For the sake 
of clarity, however, we will hereafter call the three N-CAM 
protein isoforms  N-CAM-180, -140, and  -120 whether they 
are of rat or mouse origin.  The expression  of the different 
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N-CAM-180 is produced by neurones but not by muscle cells 
whereas N-CAM-140  is associated with both cell types (9, 
40, 41). N-CAM-120  is expressed by astroeytes and muscle 
cells (9, 40, 41) and appears later in development than the 
other forms (24,  35).  The analysis of N-CAM eDNA and 
genomic sequences indicates that these protein isoforms are 
coded for by mRNAs that are derived from a single gene by 
alternative splicing (2, 24, 30, 39). 
Protein biochemical and eDNA data on rodent and chick- 
en N-CAM have shown that the main difference between 
N-CAM-180 and -140 is the size of  their cytoplasmic domains 
(13, 22,  23,  39,  41). In contrast to these N-CAM  forms, 
N-CAM-120 lacks a transmembrane domain (2, 23, 30, 41). 
Until recently its mode of membrane insertion has been un- 
clear. A source of  confusion has been that while N-CAM-120 
can be recovered in a membrane-free supernatant in soluble 
form (25) it can also be reconstituted into lipid vesicles (23). 
The most common mechanism of  membrane insertion of  cell 
surface proteins is via a stretch of hydrophobic amino acids. 
There are exceptions to this rule and some proteins are an- 
chored to the membrane by phosphatidylinositol (PI) and can 
be released by PI-specific phospholipase C  (PI-PLC) (see 
references 10, 34). The recent demonstration (29, 47) that PI- 
PLC solubilizes membrane-bound N-CAM-120 suggests but 
does not prove that this N-CAM species is also held in the 
membrane by covalently linked phospholipid. 
In light of these results we set out to study the peculiar 
mode of membrane insertion of N-CAM-120  in more detail 
and to investigate its fate from its biosynthesis to its mem- 
brane insertion and finally to its release into the extracellular 
fluid. The results show that N-CAM-120  contained PI in 
covalently  bound form and that the PI anchor was added dur- 
ing the first minutes after biosynthesis of the polypeptide. 
During biosynthesis, N-CAM-120 was first transported to the 
cell surface from which it was slowly released into the ex- 
tracellular milieu. Upon fractionation of  brain homogenates, 
most of N-CAM-120  was recovered in detergent extracts of 
membranes. Substantial amounts were found in soluble form 
and a small fraction was recovered in a nonionic detergent- 
insoluble compartment. 
Materials and Methods 
Cells and Antibodies 
The C6 rat cell line of glial origin (3) was grown in DME supplemented 
with 10% FCS, Primary cultures from postnatal day-4 mouse cerebella were 
prepared as previously described (27); they were used after 2 d  in vitro. 
The preparation and specificity of the two monoclonal antibodies, H28 
and ['61, and of the rabbit anti-mouse N-CAM serum have been described 
(25). Whereas H28 reacts with mouse but not with rat N-CAM,  P61  and 
the rabbit serum recognize N-CAM of both species.  The mouse anti-rat 
kappa  chain  monoclonal  antibody  produced  by  a  hybridoma  (kindly 
provided by H. Bazin, University of Louvain, Belgium) was purified and 
coupled to Sepharose CL-4B. 
Preparation of  ltssue Extracts and Immune 
Blot Analysis 
Mouse forebrains were homogenized in ice in 5 vol of 10% sucrose, 5 mM 
Helms, pH 7.8 containing the following protease inhibitors (referred to as 
protease inhibitor cocktail): 5 mM iodoacetamide, 0.5 mM phenylmethyl- 
sulfouyl fluoride  (PMSF),  10  U/ml  aprotinin,  5  I~M pepstatin,  40  gM 
leupeptin, and 5 ~tg/ml r  (all from Boehringer Mannheim 
GmbH, Mannheim, FRG). The homogenate was centrifuged at 2,500 g for 
20 min to eliminate cell debris, nuclei, and large mitochondria. The super- 
natant was centrifuged at 140,000 g  for  1.5 h to separate the soluble and 
crude membrane fraction. The membrane fraction was extracted for 10 rain 
with 1% NP-40 in 50 mM Tds-HCI buffer, pH 8.0, containing the protease 
inhibitors described above.  Further centrifugation at 140000 g  for 1.5 h 
yielded the nonionic detergent-soluble fraction and an insoluble pellet. In 
some cases, the final pellet was extracted in RIPA buffer (8, 50 mM Tris- 
HCI, pH 8,  150 mM NaCl,  1% NP-40,  1% deoxycholate, 0.1%  SDS) con- 
taining the protease inhibitor cocktail and again separated into a soluble and 
insoluble fraction. 
For  immune blotting,  soluble  fractions were  mixed  1:1  with double- 
concentrated SDS-PAGE sample buffer and boiled for 2 min, pellets were 
boiled directly in sample buffer. The samples were fractionated on 6.7 % gels 
and immunoreactive bands revealed after transfer to nitrocellulose as de- 
scribed (25) using 125I-protein A or  t25I-rabbit  (anti-rat Ig) antibodies as 
developing reagents for rabbit and rat antibodies, respectively. 
Labeling Procedures  and lmmunoprecipitation 
When pulse labeling with [35S]mcthiouine was to be done for 20 min, C6 
cell monolayers were washed in mcthionine-free DME and incubated in the 
same medium containing 10% dialyzed FCS in the presence of 0.5 mCi/ml 
[35S]methionine  (800 Ci/mmol; Amersham International, Amersham, UK). 
Then chase medium (DME with 2  mM methionine and  10%  FCS) was 
added and the incubation continued for the time periods specified.  The 
medium was supplemented with the protease inhibitors described above and 
centrifuged at 12,000 g for 30 rain to remove cells and debris. The cells were 
detached from the dish with I ram EDTA in PBS, collected by centrifuga- 
tion, lysed in 1% NP-40 in 10 mM Tris HCI (pH 8.0) containing 2  mM 
MgCI2  and protease inhibitors, and the lysate clarified by centrifugation 
(20 rain in an Airfuge [Beckman Instruments, Inc., Palo Alto, CA] at 20 
psi). 
For 2-min pulse labeling with  [35S]methionine, the monolayers  were 
deprived of endogenous methionine by incubation for 30 rain in methionine- 
free DME with 10% dialyzed FCS before addition of 1.4 mCi/ml 135S]me  - 
thionine. After 2 min, the cell layer was either rinsed with ice-cold chase 
medium and the cells harvested as described below (0 time point), or the 
chase was initiated with a brief rinse with prewarmed chase medium and 
the  incubation continued  in the same  medium.  After the time periods 
specified, the culture dish was put on ice and the cells scraped off into PBS 
containing 3  mM EDTA and the protease inhibitor cocktail but omitting 
iodoacetamide and PMSE The cells were pelleted, taken up in 50 mM Tris 
HC! (pH 7.5) containing 1 mM MgC12, and the protease inhibitor cocktail 
and disrupted by sonication (three times for 1 s in ice). The cells were lysed 
in 1% NP-40 (containing 4 mM EDTA to inhibit divalent cation-dependent 
processes). The lysate was further processed as in the case of the 20-rain 
pulse experiments. Soluble and membrane fractions were prepared by cen- 
trifugation through a sucrose cushion. This procedure was adopted since, 
in the case of a  2-min pulse experiment,  we encountered difficulties in 
cleanly separating soluble from membrane-associated labeled material by 
simple centrifugation. Accordingly, the sonicated cells (0.3 nil) were layered 
over 0.13 ml of 0.25 M sucrose containing 50 mM Tris HCI (pH 7.5), 2.5 
mM EDTA, 0.2 mg/ml BSA and the protease inhibitor cocktail. After cen- 
trifngation (25 psi for 45 rain in an Airfuge; Beckman Instruments, Inc.), 
the overlayered phase was withdrawn (soluble fraction) and the pellet taken 
up in 50 mM Tris HC1 (pH Z5).containing  1.5 mg/ml BSA and protease 
inhibitors. The sucrose layer, which contained between 20 and 40% of the 
IUA-precipitable  counts,  was  discarded.  Recovery  of  TCA-precipitable 
counts applied to the gradient was ,'~80%. 
The incorporation of fatty acid residues into N-CAM was analysed using 
[3H]palmitic acid. Palmitic acid (9,10-3H-;  30 Ci/mmol; New England Nu- 
clear, Cambridge, MA) was dried under N2 and redissolved in a small vol- 
ume ofdimethyl sulfoxide. C6 cell monolayers were washed with DME with 
5%  FCS and then incubated in the same  medium in the presence of  1 
mCi/ml of the tritiated fatty acid for 24 h. Then, the medium was removed, 
the cells scraped off the dish in PBS containing 3 mid EDTA, and lysed in 
boiling deoxycholate (18) to prevent enzymatic hydrolysis of a labile ester 
bond. The samples were supplemented with protease inhibitors and clarified 
by centrifugation (20 rain in an Airfuge [Beckman Instruments, Inc.] at 25 
psi). 
For labeling with [3H]ethanolamine, (26 cell monolayers were incubated 
in the presence of 0.18 mCilml of ethanolamine (1-3H; 30 Ci/mmol; Amer- 
sham International) in DME with 10% dialysed FCS for 22 h. The cells 
were processed as described for [3H]palmitic acid labeling. When labeled 
N-CAM was to be isolated from the medium, the culture supernatant was 
first centrifuged at 12,000  g  for 30 rain to remove cells and debris. 
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elsewhere (27).  After iodination, the monolayer was washed three times 
with PBS containing 2% horse serum, 5 mM KI, and 100 U/mi aprotinin. 
The cells were then either scraped from the dish and lysed  in 1% NP-40 
or incubated for 12 h with serum-free DME containing 100 U/nil aprotinin 
and 0.2 mg/ml BSA. The medium was then harvested, supplemented with 
0.5 mM PMSF and 5 gM pcpstatin as additional protease inhibitors, cen- 
trifuged for 1.5 h at 140,000 g, and the supernatant dialysed  against PBS. 
Radiolabelcd N-CAM was isolated from cell lysates, culture media, or 
NP-40 lysates of membranes by immunoprecipitation  (23). Rat N-CAM was 
precipitated by rabbit anti-mouse N-CAM antiserum (5 ~tl), mouse N-CAM 
by the H28  monoclonal antibody (10 Itg).  Antigen-antibody complexes 
were bound to either protein A coupled to Sepharose  beads (Pharmacia, 
Uppsala, Sweden) or to mouse anti-rat kappa chain monoclonal antibody 
coupled to Sepharose, for rabbit and rat antibodies, respectively.  The pre- 
cipitations with H28  or the polyclonal  antibodies were quantitative as 
judged from the observation that no specific bands were precipitated  by the 
same antibody from supernatants of a first round of immunoprecipitations 
(results not shown). The immunoprecipitates  were washed and dissolved in 
SDS-PAGE sample buffer as described (52).  In this method, the beads are 
washed consecutively with RIPA buffer and 0.01% SDS to eliminate the risk 
of precipitating noncovalenfly associated  material. The samples were frac- 
tionated on 6.7% gels, and the dried gels exposed  to Fuji RX films in the 
presence of sensitizing screens.  For 3H- and 35S-labeled samples the gels 
were impregnated with Enhance (New England Nuclear) before drying. Ex- 
posure times were t d for iodinated, 1 (20-min pulse) to 10 d (2-min pulse) 
for 3SS-labelcd, and 2 wk for 3H-labeled material. 
Peptide Mapping 
"Soluble" N-CAM-120 was isolated from a sucrose extract of adult mouse 
brain, "insoluble" N-CAM-120 from a RIPA buffer extract of the NP-40--in- 
soluble pellet by immunoprecipitation with H28  antibodies coupled  to 
Sepharose CL 4B.  As control, immunoprecipitation with P61  antibodies 
was used since P61 does not recognize N-CAM-120 (25). The bound antigen 
was detached from the beads by incubation in 1% SDS for 20 rain at 3"/~ 
and the proteins released into the supernatant were iodinated with chlora- 
mine T (23). The labeled material was fractionated on a 6.7% gel, the band 
corresponding to N-CAM-120 excised and subjected  to limited protcolysis 
with Staphylococcus aureus V8 protease  (Sigma Chemical Co., St. Louis, 
MO) according to Cleveland et al. (7) with the modifications  described (52). 
In a different type of experiment, a buffer extract or the material that re- 
mained insoluble after three extractions with NP-40 and which cont~dned 
N-CAM-120 as the sole N-CAM species, were digested for 2 h at 20~  with 
0.5 gg/ml V8 protease.  The reaction was stopped by adding 1% mercap- 
toethanol and the proteins fractionated on a 12 % gel. Immunoreactive  bands 
were t~cealed  by immune blotting using rabbit anti-mouse N-CAM  an- 
tiserum. 
Enzymatic Treatments 
PI-PLC was purified from S. aureus culture supernatants according to Low 
(33). The enzyme preparation used in the present study was the same that 
had been used in previous work (29). These enzyme preparations have been 
shown before to hydrolyze  only PI and its derivatives (33) and, as shown 
in our previous work contain no detectable proteolytic activity (29). Condi- 
tions for treatment of cell lysates or culture media were identical to those 
used previously (29). Release from membrane fractions of pulse-labeled C6 
cells was tested as follows. PI-PLC in 50 mM Tris HCI (pH 7.5) was added 
to the resuspended membrane fraction of C6 cells pulse labeled for 2 min 
to a final concentration  of  25 gg/ml, controls received buffer only. The sam- 
ples were incubated for 2 h at 37~  To facilitate access of the enzyme to 
material  sequestered  inside  closed  membrane  vesicles,  two  cycles  of 
freeze-thawing were done during the incubation followed by readdition of 
PI-PLC.  After incubation, another freeze-thaw cycle was carded out. Then, 
2.5 mM EDTA was added and soluble and particulate material separated 
by centrifugation through a sucrose cushion as described above. 
Treatment with endoglycosidase  H (endo H) was done on immunoiso- 
lated N-CAM. At the end of the wash steps, the protein A-Sepharose beads 
were taken up in 20 ~tl 0.15 M Na citrate (pH 5.5) containing 0.1% SDS, 
0.01% {~-mercaptoethanol, 2 mM EDTA, 5 ttg BSA, and the protease inhibi- 
tor cocktail without iodoacetamide.  The samples were then incubated in the 
presence of 8 Itg/ml endo H (from Streptomyces plicatus; New England Nu- 
clear) for 4 h at 37~  Controls were incubated in the absence of enzyme. 
The reaction was stopped by adding I0 gtl 0.2 M Tris HCI (pH 8) and 30 gl 
double concentrated SDS-gel  sample buffer. 
An endosialidase associated with the bacteriophage PKIA specific  for 
Escherichia coli of  the capsular type K1 was purified as described (20). This 
enzyme cleaves  polymers of r  N-acetylneuraminic  acid with a 
minimum chain length of eight residues,  leaving five to seven residues  at- 
tached to the proximal  (reducing  end) side.  Samples  were incubated with 
0.4 U/ml of enzyme for 4 h at 37~  in the presence of all protease inhibitors 
except iodoacetamide.  One unit of endosialidase activity is defined as the 
amount needed to cleave 50 gg of colominic acid in 24 h at 37~ 
Results 
Evidence  for Covalent Linkage of 
Phospholipid to N-CAM-120 
We have shown before (29) that unlike N-CAMd80 or -140, 
N-CAMd20 can be solubilized from C6 cells by PI-PLC in- 
dicating that this N-CAM form is anchored in the surface 
membrane via PI. To provide evidence that N-CAM-120 in- 
deed contains covalently bound PI, we labeled C6 cells with 
[3H]palmitic  acid and isolated N-CAM by immunoprecipi- 
tation. We initially labeled the cells for 6-8 h, but under 
these conditions label was incorporated only into N-CAM- 
180 and -140 (results not shown). When we extended the la- 
beling period to 24 h, radioactive N-CAM-120  was precipi- 
tated along with N-CAM-180  and -140 (Fig.  1, lane a). To 
prove that the label in N-CAM-120 was present as H-linked 
fatty acid, lysates of labeled cells were incubated in the pres- 
ence of purified PI-PLC from S. aureus. This treatment re- 
Figure 1. 3H-Fatty acid and [3H]ethanolamine labeling of N-CAM- 
120.  C6 cells were labeled with pH]palmitic acid for 24 h  (lanes 
a-c), or with [3H]ethanolamine for 22 h  (lanes e and f) and lysed 
in boiling deoxycholate. The lysates were either processed immedi- 
ately (lanes a, b, e, and f) or incubated for 30 min at 37~  in the 
presence (lane d)  or absence (lane c) of 50  gg/ml  PI-PLC.  Im- 
munoprecipitations were performed using rabbit anti-N-CAM se- 
rum (lanes a, c, d, and e) or preimmune serum (lanes b and  f). Suit- 
able exposures of lanes c and d  were scanned with a densitometer 
under conditions in which the peak area was a  linear function of 
the exposure  time.  The values,  expressed  in arbitrary units,  are 
given in lanes c* and d* for treated and untreated samples, respec- 
tively, alongside the corresponding bands. The positions of N-CAM- 
180,  -140,  and -120 are indicated at the left.  The diffuse band in 
lane d that migrates ahead of the dye front probably represents the 
diacylglycerol liberated by PI-PLC. 
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(A) C6 cells were pulsed with [35S]methionine  for 2 min and chased 
for up to 60 min. The cells were harvested immediately after the 
pulse (time 0) or after 2,  10, and 60 rain. Immunoprecipitations 
were performed using rabbit anti-N-CAM serum (lanes 0", 2', 10', 
and 60'), and at 0 time also with preimmune serum (lane 0"*) or 
monoclonal P61  antibody (lane 0"§  A  N-CAM-180 precursor 
band (Mr 178,000) becomes visible in lane 0"+ after a longer ex- 
posure time. Arrowheads mark the position of the Mr  178, 135, 
110, and 100 ￿  103 precursor bands. The positions of the relative 
molecular mass standards run in an adjacent lane are designated  by 
the arrows, their relative molecular mass is given in kilodaltons. 
(B) Cells were harvested immediately after a 3-rain pulse and im- 
rnunoprecipitates prepared using rabbit anti-N-CAM serum incu- 
bated in the presence (lane b) or absence (lane a) of 8 ttg/ml  endo H. 
Arrowheads mark the positions of the precursor bands; the relative 
molecular mass after endo H treatment is given at the right in 
kilodaltons. 
moved about half of the label  from N-CAM-110  without 
affecting the radioactivity in N-CAM-180  and -140 (Fig.  1, 
lanes c and d).  These experiments strongly indicated that 
N-CAM-120 but not the other two forms contained covalently 
bound PI. The failure to detect fatty acid incorporation into 
N-CAM-120 after shorter labeling periods might be explained 
by the large pool size and/or slow turnover time of PI, where- 
as N-CAM-180 and -140 appeared to contain the fatty acid in 
a different type of linkage. Since removal of fatty acid label 
from N-CAM-120 was not quantitative in these experiments, 
we could not exclude that N-CAM-120 contained differently 
linked fatty acid residues in addition to those present in PI. 
Another possibility was that reutilization of the 3H during 
the 24-h labeling period has led to incorporation in the form 
of amino acids. 
In the cases where this has been studied (variant surface 
glyeoprotein of Z  brucei [VSG] [18], Thy-1 [51], acetylcho- 
line esterase,  [28]  and decay-accelerating factor [36]),  the 
phospholipid  anchor  has  been  found to  contain ethanol- 
amine, part or all of which is amide linked to the COOH 
terminus  of the  protein.  As  shown  in  Fig.  1  (lane  e), 
[3H]ethanolamine was  readily incorporated  into N-CAM- 
110 but not into the other two N-CAM proteins suggesting 
that the lipid tails bound to N-CAM-120  and the other pro- 
teins are structurally very similar. 
Early Intermediates in N-CAM-120 Biosynthesis 
Studies of the biosynthesis and  processing  of VSG  have 
shown that, immediately after its synthesis on membrane- 
bound polysomes, a stretch of COOH-terminal hydrophobic 
amino acids  is  removed and replaced by a  complex,  PI- 
containing glycolipid. This process is completed within 1 
rain after translation (1,  17). A  similar mechanism is as- 
sumed to take place during biosynthesis of mammalian pro- 
teins that contain covalently bound PI (10, 34). However, the 
early kinetics of their processing have never been described, 
probably, in part, because of the difficulties in incorporat- 
ing sufficient amounts of radioactivity during a short pulse. 
To  investigate this point,  we pulse-labeled C6  cells  with 
[35S]methionine for 2 rain followed by a chase for up to 60 
rain. Despite the short pulse time, we were able to specifi- 
cally immunoprecipitate labeled bands with anti-N-CAM 
serum (Fig. 2 A). At 0 time of chase, three major labeled 
polypeptides were observed that migrated with Mrs of 135, 
110, and  100  x  103. Their immunoprecipitation appeared 
specific since they were absent when preimmune serum was 
used (Fig. 2 A, lane 0'*).  C6 cells synthesized only small 
amounts of  N-CAM-180; the band of weaker intensity of cor- 
responding Mr (178,000) probably represents the precursor 
of this  N-CAM  form.  A  fuzzy band  migrated in the Mr 
94,000 region. Its relative intensity varied from experiment 
to experiment and it increased in intensity upon incubation 
of cell lysates at 37"C. It might thus represent a breakdown 
product of one of the other chains; however with our present 
data we cannot exclude the possibility that it represented a 
biosynthetic intermediate. 
The most striking change observed at early times after ini- 
tiation of the chase was the rapid disappearance of the Mr 
100,000 precursor form, possibly as a result of conversion 
into the Mr  110,000 species.  The Mr  100,000 band had al- 
ready become faint after a chase period of 2 min and had 
nearly disappeared by 10 min (Fig. 2 A). Subsequently, be- 
tween 10 and 60 rain, the Mr 110 and 135  ￿  103 precursors 
were apparently processed to the mature N-CAM-120  and 
-140 proteins (we found values of Mr  147,000 and  113,000 
for the mature N-CAM-140 and -110 proteins synthesized by 
C6 cells).  However,  bands comigrating with the precursor 
forms persisted during the 60-min chase period. We had no 
explanation as to why precursor bands persisted after a short 
pulse for prolonged periods, whereas they had completely 
disappeared at comparable times after a longer pulse (com- 
pare with Fig. 4). The slight but reproducible increase in mo- 
bility of the Mr 110 and 135  ￿  103 bands between 2 and 10 
min, we assumed, represented trimming of the glucose and 
mannose residues from the core oligosaccharide. To obtain 
further evidence that the Mr 110 and 100  ￿  103 bands were 
precursor forms of N-CAM-110 and the Mr 135,000 band of 
N-CAM-140, the monoelonal antibody P61 was used. This anti- 
body recognizes a determinant located in the cytoplasmic do- 
main of  N-CAM-180 and -140, which is absent from N-CAM- 
110 (25). P61 did not precipitate the Mr 110,000 and 100,000 
precursors  (Fig.  2  A  lane 0'§  The  polypeptide band  of 
Mr  178,000 became visible after prolonged exposure  (not 
shown). 
Newly  synthesized  N-glycosylated  proteins  bear  only 
oligosaccharides of the high mannose type that are suscepti- 
ble to cleavage by endo H (32) (0-1inked sugars are believed 
to be attached during later processing in the Golgi appara- 
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precursor forms in membranes from pulse-labeled 
cells. (A) C6 cells pulse-labeled with l~SS]methio  - 
nine for 2 min were disrupted by sonication and 
membranes prepared by centrifugation through a 
sucrose cushion. The membranes were incubated 
in the presence  or absence of PI-PLC for 2 h at 
37~  After the incubation, soluble (lanes a and b) 
and particulate (lanes c and d) material were again 
separated by centrifugation through a sucrose cush- 
ion.  Arrowheads  mark the positions  of the Mr 
178, 135, 110, and  100  x  103 precursors;  the Mr 
178,000 band became only visible after prolonged 
exposure times. The positions of relative molecu- 
lar mass standards  run  in  an  adjacent  lane  are 
designated by the arrows, their relative molecular 
mass is given in kilodaltons.  (B) Suitable expo- 
sures of the fluorograph were scanned with a den- 
sitometer under conditions in which the peak area 
was proportional to the exposure time. The crude 
values measured for the peak areas were divided 
by the total TCA-precipitable radioactivity recov- 
ered in the soluble and particulate fractions to cor- 
rect for variable losses occuring during separation. 
The values obtained for the Mr 100, 110, and  135 
x  103 bands in  soluble  (S) and particulate  (P) 
fractions are given in arbitrary units. The soluble 
fraction did not contain a measurable peak for the 
Mr 135,000 band. 
tus).  Digestion  with  endo  H  of immunoisolated  N-CAM 
pulse labeled for 3 min was used to exclude the possibility 
that the Mr  100,000 precursor might be a  glycosylation in- 
termediate. As illustrated in Fig. 2 B, treatment with endo 
H  resulted in large shifts of the Mr 135, 110, and 100  x  103 
bands.  However, the reduction  in relative molecular mass 
was not the same for the three chains. It was smallest for the 
Mr 135,000 band (,~10,000),  highest for the Mr 110,000 band 
(~20D00),  and  intermediate  for  the  Mr  100,000  band 
(,',,15,000).  Recent sequence data for mouse N-CAM show 
the presence of six potential sites for N-linked glycosylation 
(2). Cleavage of six Glc3MangGIcNAc2 structures would re- 
sult in a shift of Mr 10-15  x  103 and it is unclear at present 
what causes the higher relative molecular mass reduction in 
apparent relative molecular mass of the 110,000 precursor. In 
any case, it became rather clear that the Mr 100,000 protein 
was  not  a  glycosylation intermediate of one of the  other 
chains. After endo H treatment, a fainter band appeared that 
migrated slightly  behind  the Mr  133,000  species.  It might 
represent incompletely deglycosylated molecules. Together, 
the data indicated that the Mr 100 and 110  x  103 forms were 
both precursors of N-CAM-120 and that the differences be- 
tween these two components were not due to differences in 
glycosylation. 
To investigate which of the precursors of N-CAM-120 had 
already acquired a phospholipid tail, experiments with PI- 
PLC  were performed.  Accordingly,  a  membrane fraction 
prepared from cells pulse labeled for 2 min was incubated 
in the presence or absence of S. aureus PI-PLC. To facilitate 
the  access  of the  enzyme to  material  sequestered  inside 
closed  vesicles,  two  freeze-thaw  cycles  were  performed 
during  the  incubation.  After  the  incubation,  soluble  and 
membrane-associated material were again separated by cen- 
trifugation through a sucrose cushion. In the absence of en- 
zyme, part of the Mr 100,000 polypeptide, but very little of 
the other components,  was released from the membranes 
(Fig.  3 A, lanes a  and c).  PI-PLC treatment increased the 
amount of the Mr 110,000 polypeptide recovered in the solu- 
ble fraction (Fig. 3 A, lanes b and d). To evaluate the distri- 
bution of the different forms between soluble and membrane- 
bound material in a more quantitative way, the fluorographs 
were scanned by densitometry. The results showed that PI- 
PLC released substantial amounts of the Mr  110,000 bands 
from the membranes without affecting the distribution of the 
Mr 100,000 component (Fig. 3 B). There was no difference 
in migration between the soluble and membrane-bound Mr 
110,000 forms; as has been observed before for the mature 
N-CAM-120 protein (29)  cleavage of the lipid component 
does not lead to a detectable relative molecular mass shift. 
As  expected,  PI-PLC  did  not  solubilize  the  Mr  135,000 
band, which should contain a transmembrane domain. These 
results thus  showed that the Mr  U0 but not the  100  x  103 
component had already acquired the phospholipid tail at the 
onset of the chase. 
Cultured Cells Release N-CAM-120 into the Medium 
The attachment of a cell surface protein via a phospholipid 
anchor may provide a mechanism for the release of plasma 
membrane proteins into the extracelhlar milieu by endoge- 
nous phospholipases. To detect release of N-CAM-120 from 
the surface membrane without addition of exogenous PLC, 
we conducted  pulse-chase experiments using  [35S]methio- 
nine-labeled C6 cells. Immediately after the 20-min pulse, 
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C6 cells.  (A) C6 cells  were pulsed  for 20 min with [35S]methio- 
nine and chased for intervals ranging from 0 to 22 h. The chase me- 
dia were centrifuged for 30 min at  12,000 g to remove cells and 
debris, the cells were lysed in NP-40, and the N-CAM forms immu- 
noprecipitated  with rabbit anti-N-CAM serum. The immunopre- 
cipitates from cell lysates and chase media are marked cells and sn, 
respectively. Control precipitates  with preimmune serum are desig- 
nated by an asterisk (0" and 22*). Lanes TOand T2 show the results 
of experiments  in which intact cells were treated with trypsin. La- 
beled cells at 0 time and after 2 h of chase were detached from the 
culture dish with PBS/EDTA and incubated  for 10 min at 37~  in 
the presence of 1 mg/ml trypsin in DME. The digestion was stopped 
by adding 4 mg/ml soybean trypsin inhibitor  and 0.1 mg/ml PMSF. 
Cell viability was >98 % after this treatment  as judged from trypan 
blue exclusion.  The positions of N-CAM-180, -140, and -120 are in- 
dicated.  A high relative molecular mass contaminant which is also 
precipitated  with preimmune serum is seen in the supernatants.  (B) 
The radioactive bands corresponding to N-CAM-120 and -140 were 
excised from the gels and counted. The radioactivity  in each band 
was expressed in percent of the radioactivity  present at time 0. The 
solid triangles  represent  N-CAM-120 recovered with the cells,  the 
solid squares  N-CAM-120 recovered in the culture media, and the 
open triangles  N-CAM-140 recovered with cells.  There was no ra- 
dioactivity above background at the position of the N-CAM-140 
band in the supernatants  (open squares). 
labeled N-CAM-140 and -120 together with their respective 
precursors of slightly lower relative molecular mass (135,000 
and 110,000) were immunoprecipitated from C6 cell extracts 
(Fig.  4 A).  C6 cells produced relatively little N-CAM-180, 
and detection of this band required  longer exposure times 
(not shown). After 1 h of chase, the precursor bands had dis- 
appeared, and between 3.5 and 22 h a steady decline of cell- 
associated N-CAM-120 was observed. There was also some 
reduction in the amount of radioactive N-CAM-140 recov- 
ered from the cells,  but this represented only •15  %. of the 
radioactivity initially present  (Fig.  4  B) (from this decline 
a  t,~ of •80  h  could be calculated for N-CAM-140, a value 
that is in the normal range for membrane proteins [38]). By 
contrast, the amount of cell-bound N-CAM-120 declined by 
80 %.  Over the same time period,  labeled N-CAM-120 ap- 
peared in the cell-free supernatant,  a  faint band being first 
visible at 3.5 h.  A  high relative molecular mass band was 
also precipitated  from the supernatants.  It was precipitated 
nonspecifically since equivalent amounts were also found in 
control precipitates. This band might correspond to fibronec- 
tin, which has been shown to have affinity for protein A (15). 
The regions  corresponding to the N-CAM-120 and  -140 
bands  were cut out from the dried  gels and counted.  The 
results  obtained  for  N-CAM-120,  expressed  as  percent  of 
N-CAM-120 recovered at 0  time of chase are shown in Fig. 
4 B. Labeled N-CAM-120 was lost from the cells with a half- 
life of ~11 h and appeared with identical kinetics in the su- 
pernatant.  To confirm that N-CAM-120 was present  at the 
cell surface before being released in the incubation medium, 
cells chased for 0  or 2 h  were slightly trypsinized.  Trypsin 
had little effect on the cellular content of N-CAM at 0 time, 
but N-CAM-120,  as  well  as  N-CAM-140,  were completely 
lost from the cells after 2 h of chase (Fig. 4 A, lanes TO and 
T2). These results thus showed that N-CAM-120 was exter- 
nalized by C6 cells in a trypsin-sensitive location from which 
it was slowly released  into the medium. 
We considered the possibility that N-CAM-120 might be 
lost from the cell surface with the lipid tail still attached to 
it. To investigate this point and to obtain information on the 
mechanism of  the spontaneous release process, the following 
experiment was carried out. Of six sister cultures of  C6 cells, 
two were  labeled  with  [35S]methionine,  two  with  [3H]eth- 
anolamine, and two with [3H]palmitic acid. After 22 h, one 
Figure  5.  Cultured  cerebellar 
cells release  N-CAM-120 into 
the medium.  Monolayer cul- 
tures prepared from P4 mouse 
cerebella  were  surface  iodi- 
nated and the cells either lysed 
directly in NP-40 or incubated 
for  12  h  in  fresh  medium. 
N-CAM  proteins  were  iso- 
lated from 140,000 g supema- 
tants of cell lysates and media 
by immunoprecipitation  with 
antibody  H28.  The  precipi- 
tates  from the culture  media 
were incubated for 4 h at 37~ 
in the presence or absence of 
0.4 U/ml PK1A endosialidase.  (A) The pattern  of total  iodinated 
proteins  in the medium; (B) the immunopreeipitates.  Sn, untreated 
immunoprecipitate  from the  medium supernatant;  Sn+E,  endo- 
sialidase-treated  immunoprecipitate  from the medium supematant; 
D, immunoprecipitate from the detergent lysate. The positions of the 
relative molecular mass standards  are indicated,  their relative mo- 
lecular mass is given in kilodaltons. 
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Precursors from C6 Cells 
Label  Cells  Cells  Medium  A cells 
Oh  6h  6h 
[3~S]Methionine  34.9  25.0  10.4  9.9 
100%  72%  30%  28% 
[3H]Ethanolamine  34.2  25.7  4.8  8.6 
100%  75%  14%  25% 
[3H]Palmitic acid  8.3  6.3  <0.3  2.0 
100%  76%  -  24% 
Parallel  cultures of C6 cells were labeled for 22 h with either 0.18  mCi/ml 
[3SS]methionine, or with 0.18  mCi/ml  [~H]ethanolamine, or with 0.6  mCi/ml 
[3H]palmitic acid. Then, the culture dishes were washed with complete medi- 
um with 10% FCS and incubated for 6 h in chase medium which consisted of 
DME with 10%  FCS,  to which had been added  130 l~g/ml cycloheximide (a 
concentration  sufficient to  reduce  protein  synthesis  by  98%)  and  5  ~tg/ml 
r  and  10  U/ml  aprotinin  as  protease  inhibitors.  After  the 
chase period,  the cells were detached in PBS-EDTA and lysed immediately in 
boiling  1% deoxycholate. The medium was centrifuged for 30 min at 12,000 g 
to remove cells and debris.  N-CAM proteins were isolated from cells and the 
medium supernatant by immunoprecipitation and fractionated by SDS-PAGE. 
Suitably exposed (i.e., in the linear range of the film response) autoradiographs 
were scanned with a densitometer,  the results are expressed as arbitrary units. 
The zero time point (0 h) was done on sister cultures that were processed after 
the 22-h labeling period. A ceils, difference between the radioactivity associat- 
ed with cell-bound N-CAM-120 at zero time and after the 6-h chase.  No de- 
tectable decrease in pS]methionine or [3H]palmitic acid recovered with cell- 
bound  N-CAM-140 was observed  during the chase period. 
of each pair of cultures was harvested. Cold chase medium 
was added to the remaining three and the incubation con- 
tinued for another 6 h. N-CAM proteins were then isolated 
and  the  radioactivity  associated  with  N-CAM-120  deter- 
mined by scanning  suitable exposures of the gels by den- 
sitometry. As shown in Table I, "o30% of [35S]methionine- 
labeled N-CAM-120 was lost from the cell surface during the 
chase period and equivalent amounts were recovered in the 
medium, Over the same time period, there was a 25 % reduc- 
tion in the amount of 3H-fatty acid recovered with the cell- 
bound N-CAM-120, but no radioactivity could be detected in 
the released protein.  There was also a  ,o25 % reduction in 
[3H]ethanolamine-labeled cell-bound N-CAM-120, but sur- 
prisingly, only around half of it was recovered with the mole- 
cules released into the medium.  It was thus clear that the 
N-CAM-120 recovered in the extracellular milieu had lost the 
lipid part of its COOH-terminal anchor, but additional hy- 
potheses were needed to explain the partial loss of ethanol- 
amine. 
To test whether primary cultures of brain cells would also 
release  N-CAM-120,  surface-iodinated  cultures  of  young 
postnatal  mouse  cerebella  were  used.  After  labeling,  the 
cells were incubated for 12 h  and the N-CAM proteins re- 
leased  into  the  medium  isolated  by  immunoprecipitation 
(Fig.  5 B).  The material recovered from the medium con- 
sisted  of Mr  120,000  band  plus  some  diffuse  material  of 
slower mobility. In contrast to C6 cells, these cultures might 
thus  synthesize  polysialylated N-CAM.  Indeed,  treatment 
with endosialidase (20) removed the diffuse zone leaving a 
well defined band that co-migrated with N-CAM-120.  Clearly, 
cerebellar  cells  spontaneously  released  N-CAM-120,  part 
of which was in polysialylated form, into the extracellular 
milieu. Since these cells do not proliferate, they incorporate 
low amounts of [35S]methionine  and precise pulse-chase ki- 
netics could not be established as in the case of C6 cells. 
Figure 6. Sequential extraction of N-CAM-120 from mouse brain. 
A P21 mouse brain homogenate was separated into a soluble and 
a membrane fraction.  The membranes  were extracted twice with 
1% NP-40 and once with RIPA buffer and the insoluble final pellet 
with either l0 mM Tris-HC1, pH 8.0, or with 1% NP-40. All extracts 
were centrifuged for 1.5 h at 140,000 g. N-CAM proteins were re- 
vealed by immune blotting using  H28 antibody. Around 200  ~tg 
protein were applied to each lane. Lane 1, soluble fraction; lane 2, 
first NP-40 extract; lane 2', same as lane 2, but less protein was ap- 
plied  to reveal the bands;  lane 3,  second NP-40 extract;  lane 4, 
RIPA buffer extract; lane 5, the pellet after RIPA buffer extraction; 
lane 6, the material released from the RIPA buffer-insoluble  pellet 
with 10 mM Tris-HCl; lane 7, the material released from the RIPA 
buffer-insoluble  pellet with 1% NP-40. The positions of N-CAM- 
180, -140, and -120 are indicated. 
Solubility Characteristics of  N-CAM-120 in 
Mouse Brain 
Previous studies have shown that N-CAM-120 from rodent 
brain is partially recovered in a buffer extract in soluble form 
(25). When a brain homogenate from postnatal day-21  (P21) 
mouse brain was fractionated into a buffer-soluble, a NP-40- 
soluble and a  NP-40-insoluble fraction,  we again found a 
N-CAM-120 band in the buffer extract (Fig. 6, lane 1 ). The 
immunoreactive material of higher relative molecular mass 
might represent highly sialylated N-CAM which is still found 
at this age (19, 31). Surprisingly, however, N-CAM-120, but 
not the higher relative molecular mass chains, was still pres- 
ent in the material that remained insoluble, and only part of 
it could be extracted by a SDS-containing detergent mixture 
(Fig. 6, lanes 4 and 5). Equal amounts of protein were loaded 
on each lane to evaluate the relative enrichment of N-CAM- 
120 in the different fractions. Further treatment of the pellet 
with buffer or NP-40 did  not release any immunoreactive 
material (Fig. 6, lanes 6 and 7). In Fig. 8, a quantitative esti- 
mation of the relative amounts of the N-CAM-120 forms with 
different  solubilities  is  shown.  This  estimation  was  done 
by cutting the corresponding regions out of the nitrocellu- 
lose paper for counting.  Control experiments with purified 
N-CAM  established  that  within  the  range  measured,  the 
amount of radioactive second antibody bound was propor- 
tional to the amount of N-CAM present (not shown). In the 
adult mouse brain, "o25 % of the total N-CAM recovered was 
found in the soluble fraction, slightly >70% in the NP-40 ex- 
tract, and <6%  in the insoluble pellet. 
Conceivably,  soluble  and  insoluble  N-CAM-120  could 
represent quite distinct polypeptides. To approach this ques- 
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mapping of soluble and insoluble 
N-CAM-120.  (.4) N-CAM pro- 
teins  were  immtmoprecipitated 
with antibody H28 from a Hepes- 
buffered sucrose extract of adult 
mouse brain (lane 1) or from a 
RIPA buffer extract of the NP- 
40-insoluble  material  (lane  3) 
and radioiodinated. Precipitation 
with antibody P61 served as con- 
trol (lanes 2 and 4), no labeled 
band was detected in the N-CAM- 
120 region. (B) The bands cor- 
responding to N-CAM-120 were 
cut out from the gel shown in A 
and subjected to limited proteoly- 
sis. Lanes 1, 3, and 5, soluble N-CAM-120; lanes 2, 4, and 6, insoluble N-CAM-120; lanes 1 and 2, 1 ng S. aureus V8 protease; lanes 
3 and 4, 100 rig; lanes 5 and 6, 300 rig. (C) A Hepes-buffered sucrose extract and the material that remained insoluble after three NP-40 
extraction was treated with 0.5 ttg/ml S. aureus V8 protease and the immunoreactive material revealed by immune blotting using rabbit 
anti-N-CAM serum. Lanes I and 3, soluble N-CAM-120; lanes 2 and 4, insoluble N-CAM-120; lanes I and 2, control without protease; 
lanes 3 and 4, digested samples. The arrowheads indicate the position of the immunoreactive bands in the protease-treated material. 
tion, the peptide maps of the two types of molecules gener- 
ated by limited proteolysis were compared. Buffer-soluble 
and NP-40--insoluble  N-CAM-120 were immunoprecipitated, 
iodinated, and repurified by gel electrophoresis. Both molec- 
ular forms yielded identical patterns of iodinated peptides 
(Fig.  7 B).  In a  different type of experiment, soluble and 
insoluble N-CAM-120 were slightly digested with S. aureus 
V8  protease and the fragments revealed by immune blot- 
ting (Fig.  7  C).  Again,  fragments of identical sizes were 
generated. 
To test whether some of the N-CAM-120 recovered with 
brain membranes was loosely bound and thus constituted a 
potential source of the form recovered in the buffer extracts, 
a microsomal pellet was resuspended in different media fol- 
lowed by high speed centrifugation. Of the various treat- 
ments tried, i.e., 3 M  NaCI, pH  11, mercaptoethanol, and 
urea plus mercaptoethanol, only the latter released N-CAM- 
120 into the supernatant (results not shown). However, in the 
presence of urea N-CAM-180 and -140 were also recovered 
in the supernatant. In fact, only a very small amount of  mem- 
brane protein was pelleted in  8  M  urea; apparently small 
membrane vesicles were generated, which, due to the high 
density of the urea solution, were prevented from sediment- 
ing. Clearly, the N-CAM-120 recovered in a membrane frac- 
tion could not be released by treatments that solubilized pe- 
ripheral membrane proteins. 
Forms of  N-CAM-120 in the Developing Mouse Brain 
In the embryonic mouse brain, N-CAM is present in a poly- 
sialylated form that  migrates  as  a  diffuse zone in  which 
individual  proteins  cannot be  resolved (26,  31).  Distinct 
N-CAM-180,  -140, and -120 bands gradually appear during 
postnatal development, but the diffusely migrating material 
is present up to P21. To reveal the underlying polypeptides 
we used an endosialidase, which rapidly and quantitatively 
cleaves the sialic acid polymers (20). As shown in Fig. 8 A 
for a P15 brain, which contains a mixture of highly and less 
sialylated N-CAM, treatment with this enzyme ledto the dis- 
appearance of the diffusely migrating zone at the top of the 
gel and enhanced the N-CAM-180,  -140, and -120 bands to 
approximately the same extent. Incubation in the absence of 
enzyme had  no effect. This experiment thus  showed that 
N-CAM-120 was polysialylated in the brain. It was not sur- 
prising that polysialylated N-CAM-120 migrated above the 
N-CAM-180 band since previous results showed that a  Mr 
45,000 polysialylated N-CAM fragment was migrating with 
an apparent Mr of 170,000 (23). 
To determine the timing of appearance and the relative 
proportions of buffer-soluble, NP-40-soluble, and NP-40- 
insoluble  N-CAM-120,  the  corresponding  fractions  were 
prepared from mouse brains of different ages, endosialidase 
treated, and the N-CAM proteins were revealed by immune 
blotting (Fig. 8 B). We made two quantitative analyses of the 
data. The change in total N-CAM-120 concentration was esti- 
mated by adding the radioactivity bound by the N-CAM-120 
band in each fraction (solid triangles in Fig. 8 C). There was 
a fourfold increase in total N-CAM-120 concentration in the 
brain between P8 and adult ages.  To evaluate the relative 
amounts of each N-CAM-120  form of different solubility, 
the crude counts were corrected for differences in the vol- 
umes of the three fractions and expressed as percent of total 
N-CAM-120 (open bars in Fig.  8 C). A higher percentage 
of soluble N-CAM was found in the embryo, but also in the 
adult, as compared with young postnatal ages. Overall, it be- 
came clear that from P15 onwards substantial amounts of the 
different N-CAM  forms  were recovered in  an apparently 
buffer-soluble form. Regardless of age, the bulk of N-CAM- 
120 was recovered in the NP-40-soluble form. 
Discussion 
In our initial report, we showed that PI-PLC solubilizes a 
substantial fraction of N-CAM-120 from brain microsomes 
and quantitatively releases N-CAM-120 present at the sur- 
face of C6 cells without affecting the other two N-CAM spe- 
cies (29). This data and similar results obtained by another 
laboratory (47)  indicate that N-CAM-120 is a  member of 
the group of membrane proteins that are anchored to the 
The Journal of Cell Biology, Volume 105,  1987  2496 Figure  8.  Developmental 
changes  in  N-CAM-120 ex- 
pression  in mouse brain  and 
quantification of its distribu- 
tion  between  different  frac- 
tions. (A) The effect of endo- 
sialidase treatment on a NP-40 
extract from a PI5 forebrain. 
(Lane  C)  Control  sample, 
boiled  immediately  in  SDS- 
PAGE sample  buffer;  (lane 
§  sample incubated in the 
presence, (lane -E) in the ab- 
sence of PKIA endosialidase. 
N-CAM bands were revealed 
with  H28  monoclonal  anti- 
body. (B) Immune blot anal- 
ysis  of N-CAM proteins  in 
different fractions during de- 
velopment.  Forebrains  from 
embryonic day-17 (El7), P2, P8, P15, and adult mice were homogenized in Hepes-butfered sucrose and separated into a soluble fraction(s), 
a NP-40 extract (d), and a NP-40-insoluble pellet (p). The different fractions were treated with endosialidase and the proteins separated 
by SDS-PAGE. Total volumes were 4.5 ml for the Hepes/sucrose extract, 13 ml for the NP-40 extract, and 3.4 ml for the insoluble material 
after addition of SDS-PAGE sample buffer. The blot was developed with H28 monoclonal antibody. (C) The quantifications of N-CAM-120 
obtained by cutting out and counting the regions corresponding to the N-CAM-120 band in B. The values are expressed as percent of 
N-CAM-120 recovered at each age. These values are shown in the histograms ([] soluble, [] NP-40, ￿9 insoluble fraction).  The sum of the 
counts in the three fractions was then divided by the sum of  the amounts of  protein charged on the gel; these values are expressed in arbitrary 
units (AU) and allow assessment of the changes in N-CAM-120 concentration during development (A). 
membrane by PI. This group includes alkaline phosphatase, 
5'-nucleotidase, acetylcholine esterase, Thy-1,  T  cell-acti- 
vating protein, decay accelerating factor, and VSG (14,  18, 
34,  36,  43,  51).  N-CAM is already known to have several 
modes of posttranslational modifications, namely N-linked 
glycosylation, polysialylation, phosphorylation, and sulfata- 
tion (11, 19, 25,  35,  37, 41, 49).  The presence of PI in one 
N-CAM form not only adds yet another mode ofposttransla- 
tional modification to this list but also r~ses the possibility 
that this N-CAM isoform may be selectively released from 
cell surfaces. In the present study we provide evidence that 
N-CAM-120 indeed contains covalently bound PI and that it 
is spontaneously released into the extracellular milieu. We 
further show that the PI anchor is added very early during 
biosynthesis and have investigated the solubility characteris- 
tics of this N-CAM species in brain tissue. 
When C6 cells are labeled with [3H]palmitic acid, label is 
incorporated into all three N-CAM proteins. PI-PLC treat- 
ment removes the label only from N-CAM-120 demonstrat- 
ing that in this N-CAM isoform the fatty acid, at least in part, 
is present in covalently bound phospholipid. Although de- 
tailed structural information is not yet available for N-CAM- 
120, it seems likely in analogy with rat Thy-1 (51) and T. bru- 
cei VSG (18) that the linkage between the protein and PI 
involves an ethanolamine- and glucosamine-containing gly- 
can.  This conclusion is supported by our observation that 
N-CAM-120 can be labeled with [3H]ethanolamine.  Since 
neither  N-CAM-180  nor  -140  incorporate  this  precursor, 
these experiments rule out the possibility that the two larger 
N-CAM isoforms bear a similar kind of structure. 
Short-time pulse-labeling experiments have been done to 
investigate the early kinetics of NCAM synthesis. Three ma- 
jor labeled polypeptides are seen after a 2-min pulse with 
[35S]methionine.  Two of them (Mr 135 and  110  x  103) are 
relatively long lived and are assumed to correspond to the 
core-glycosylated  precursors of N-CAM-140 and -120, respec- 
tively. The Mr 110,000 precursor form has already acquired 
the PI tail at the onset of the chase since it can be released 
from membranes by PI-PLC.  VSG is initially synthesized 
with a hydrophobic COOH-terminal peptide which is subse- 
quently cleaved and replaced by glycophospholipid within 
1-2 min after completion of the polypeptide (1, 5,  17).  A 
comparison of  eDNA with protein sequences of  the Thy-1 an- 
tigen suggests that a similar mechanism may take place in 
mammalian ceils (51). Recent eDNA data for chicken (30) 
and mouse (2) N-CAM indicate that N-CAM-120 may also 
initially be  synthesized with  a  COOH-terminaI  stretch of 
hydrophobic amino acids. It appears from our studies that 
addition of  the phospholipid is also a very rapid step in mam- 
malian cells. The enzymes involved would presumably re- 
side close to the site of protein synthesis in the endoplasmic 
reticulum. This assumption is supported by our finding that 
the Mr 110,000 precursor, which is the first detectable form 
with a PI anchor, also bears oligosaccharides that are suscep- 
tible to endo H digestion. The specificity of this enzyme for 
high mannose  oligosaccharides has  been well established 
and susceptibility to endo H has been taken as indication that 
the protein has not yet reached the Golgi apparatus (32). It 
has already been shown in previous studies that mature rat 
and mouse N-CAM are resistant to endo H  (31, 35). 
In contrast to the studies on the VSG system (1,  17), we 
detect in our biosynthetic labeling experiments a short-lived 
intermediate  of  lower  apparent  relative  molecular  mass 
(100,000) which is not affected by PI-PLC treatment and 
hence, does not appear to bear a phospholipid anchor. This 
chain may correspond to one or the other of the two hypo- 
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lipid tail: the primary translation product still possessing the 
hydrophobic amino acid extension, and the form from which 
this segment has been cleaved. The solubility characteristics 
of the Mr 100,000 species are compatible with both possibil- 
ities. It is recovered in a membrane fraction, but is spontane- 
ously released upon incubation. It could be argued that the 
COOH-terminal segment of uncharged amino acids may in- 
teract more loosely with the membrane than a protein with 
a transmembrane domain and is thus released during the in- 
cubation. On the other hand, the precursor from which this 
segment has been cleaved may remain associated with the 
membrane by virtue of its  interaction with  a  membrane- 
bound  enzyme complex involved in  its  conversion.  Con- 
sideration of relative molecular mass may be taken as argu- 
ment that the 3,/, 100,000 form is the primary translation 
product; it migrates after endo H digestion with an apparent 
Mr of 85,000, a value close to the Mr of 79,000 predicted by 
the  nucleotide  sequence  (2).  The endo  H  digestion  also 
shows that the key difference between the Mr 100 and 110 x 
103  species is  not due to N-linked oligosaccharides.  The 
relative molecular mass difference of 5,000 that remains af- 
ter endo H (plus ~2,500 if the Mr 100,000 chain should not 
possess the COOH-terminal peptide segment) may be due to 
the presence of sugars in the phospholipid. Antisera recog- 
nizing the COOH-terminal peptide or the putative oligosac- 
charide moiety of the lipid tail will be important tools for 
distinguishing  these  possibilities.  Unfortunately,  antisera 
recognizing the glycan-PI complex of VSG (anti-CRD) did 
not react with N-CAM-120 (He, H.-T., and C. Bordier, and 
He, H.-T., and G. Rougon, unpublished results). 
As shown in the present study, a  substantial fraction of 
brain N-CAM-120 is recovered in high speed supernatants af- 
ter mechanical disruption of the tissue. Given the fact that 
N-CAM-120 is attached to the membrane by a phospholipid 
anchor, the soluble N-CAM-120 found in buffer extracts may 
be derived from the plasma membrane, perhaps by cleavage 
of the PI tail by endogenous phospholipases. To investigate 
this point further, we studied the sensitivity of N-CAM-120 
to trypsin treatment of intact cells and the kinetics of its re- 
lease in C6 cultures. The results establish that N-CAM-120 
is present at the cell surface before it accumulates to a sig- 
nificant extent in  the  medium  and  show  that the  decline 
in  cell-bound N-CAM-120  is  exactly counterbalanced by 
the amounts that appear in the medium.  The release is a 
rather slow process with a t,h of 11 h. Spontaneous release 
of N-CAM-120 from the plasma membrane is not a special 
feature of C6 cells, since surface-iodinated cerebellar cells 
also release labeled N-CAM-120 (but neither N-CAM-140 
nor -180) into the medium. 
To gain further insight into the mechanism of  the spontane- 
ous release process we compared the release of N-CAM-120 
labeled  with  either  [35S]methionine,  3H-palmitic acid,  or 
[3H]ethanolamine. Whatever the precursor compound, 25- 
30% of labeled N-CAM-120 was lost from the cell surface 
over the time period studied. However, whereas recovery of 
the [35S]methionine-labeled molecules in the medium was 
quantitative, [3H]palmitic acid was not detectable in the re- 
leased protein, and only half of the [3H]ethanolamine label 
was recovered in the supernatant. These data suggest several 
possible mechanisms  for the release.  One is that most of 
the shedding from the cell surface is in fact due to proteo- 
lytic attack. However, such a mechanism would require that 
N-CAM-120 is more sensitive to the release by proteases than 
the other two forms, and does not explain why around half 
of the ethanolamine is retained by soluble N-CAM-120.  A 
more likely explanation is that an initial cleavage step within 
the lipid anchor, perhaps by a phospholipase which releases 
it from the cells, renders N-CAM-120 susceptible to proteo- 
lytic attack. Finally, a more far-fetched possibility is that the 
glycolipid tail  of N-CAM-120  contains  two  ethanolamine 
residues, as has been shown for Thy-1 (51) and that the lipid 
part of it is removed by an enzyme, e.g., an endoglycosidase 
or a phosphodiesterase, in such a way that one of the two 
ethanolamine residues would remain attached to the protein. 
A precise chemical analysis of the COOH-terminal structure 
of soluble N-CAM-120 will be required to distinguish be- 
tween these possibilities. 
Upon fractionation of mouse brain homogenates N-CAM- 
120, but neither N-CAM-180 nor N-CAM-140,  was found in 
a compartment which was insoluble in nonionic detergent. 
Quantification of the  data  shows  that this  insoluble  form 
represents only 6% of total N-CAM-120,  whereas 25% are 
recovered in soluble form, and 70 % in detergent extracts of 
the membranes. We envisage that this insoluble N-CAM-120 
is derived from extracellularly deposited N-CAM-120 which 
has become resistant to solubilization by detergent. This pos- 
sibility is supported by the finding that detergent-insoluble 
N-CAM-120 is not found in C6 cell extracts and that a frac- 
tion of the N-CAM-120 released into the medium is refrac- 
tory to detergent extraction (unpublished results). In brain 
tissue,  the bulk of N-CAM-120 is present in a membrane- 
bound,  nonionic detergent-soluble form.  It cannot be re- 
leased from the membranes by treatments known to solubil- 
ize peripheral membrane proteins, and, in contrast to Nybroe 
et al. (41), we find no evidence for a mature form of N-CAM- 
120 with the characteristics of a peripheral membrane pro- 
tein. In our earlier study (29) we have found that PI-PLC 
solubilizes a maximum of 50% of N-CAM-120 from brain 
microsomes (whereas the release from the  surface of C6 
cells was quantitative). This result is to be expected if one 
assumes that 50% of the microsomal vesicles are inside out. 
It is thus likely that all N-CAM-120 recovered with brain 
membranes and soluble in detergent is held in the membrane 
by a lipid tail. 
A  striking  posttranslational  modification of N-CAM  is 
polysialylation. Previous studies have shown that N-CAM- 
180 and -140 are polysialylated (19, 24).  Our endosialidase 
digestion experiments show that N-CAM-120 is polysialy- 
lated at young postnatal ages and that it is released from 
cerebellar cells in that form. In essential agreement with 
previous studies (41), we observe an approximate fourfold in- 
crease in the concentration of N-CAM-120 during postnatal 
brain development. Over the same developmental  time course, 
striking changes in its distribution between soluble, deter- 
gent-soluble, and -insoluble fractions are not revealed. 
Based on these results we can propose the following chro- 
nology for N-CAM-120 synthesis and release. The first event 
in the processing is probably the co-translational addition of 
N-linked sugars. Attachment of the phospholipid anchor oc- 
curs immediately after synthesis of the polypeptide, when 
the protein is still in the endoplasmic reticulum. N-CAM-120 
is then transported to an intracellular site where processing 
of  the N-linked oligosaccharides occurs, including polysialy- 
The Journal of Cell Biology, Volume 105,  1987  2498 lation at early postnatal  ages. Thereafter, it is transported to 
the cell surface from which it can be slowly released into the 
extracellular fluid, probably by cleavage of the lipid tail. 
The biological significance of phospholipid-mediated mem- 
brane insertion is unknown at present. Possibly N-CAM-120 
may serve a dual role both as cell-surface molecules and as 
extracellular proteins. Since phosphoinositide-specific phos- 
pholipases are known to be activated during cell stimulation 
(4), circumstances may exist in which release of N-CAM-120 
from neural cell surfaces may be specifically triggered.  The 
interest in extracellular N-CAM is heightened by the recent 
findings (8) that N-CAM is present in adherons, i.e., macro- 
molecular complexes that are shed from cultured cells and 
mediate cell-extracellular matrix interactions. Another pos- 
sibility is that the phospholipid tail is involved in transmem- 
brane signaling. The cleavage of PI by PI-PLC liberates  1,2 
diacylglycerol, a molecule of known second messenger func- 
tion (see reference 4), and at least two lymphocyte surface 
proteins that are anchored in the membrane by phospholipid 
have been implicated in cellular activation (42, 43). 
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